Who invested in Iterum Therapeutics?
Iterum Therapeutics's investors include Canaan, RA Capital Management, Domain Associates, Bay City Capital and Pivotal bioVenture Partners, and 1 more on record.

Ireland · Funded startup
Funding summaryUpdated 26 Oct 2026
$67Mraised across 2 rounds since 2017, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $46M sold, first sale May 2017
From Iterum Therapeutics's own website: 2 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Iterum Therapeutics's investors include Canaan, RA Capital Management, Domain Associates, Bay City Capital and Pivotal bioVenture Partners, and 1 more on record.
Iterum Therapeutics has raised $67M across 2 rounds since 2017.
Iterum Therapeutics's most recent round was an Undisclosed round of $2.2M in Aug 2025.
Iterum Therapeutics's largest round on record is $65M (Series B), in May 2017.
Iterum Therapeutics's first round on record, in May 2017, was backed by Domain Associates, Bay City Capital and Pivotal bioVenture Partners and 1 others.
Iterum Therapeutics's latest named round is an Undisclosed round, in Aug 2025.
Iterum Therapeutics is based in Ireland.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.